FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel condensed cyclopropylpyrrolidines of the formula: wherein x means 0 or 1 and y means 0 or 1 under condition that x means 1 when y means 0, and x means 0 when y means 1; and wherein n means 0 or 1; X means hydrogen atom (H) of group -CN; R1, R2, R3 and R4 are similar or different and chosen independently from H, (C1-C10)-alkyl, (C2-C12)-alkenyl, saturated (C3-C10)-cycloalkyl, saturated (C3-C10)-cycloalkyl-(C1-C10)-alkyl, saturated (C3-C10)-bicycloalkyl, saturated (C3-C10)-tricycloalkyl, hydroxyl-(C1-C10)-alkyl-saturated (C3-C10)-cycloalkyl, (C1-C10)-alkylthio-(C1-C10)-alkyl, (C6-C10)-aryl-(C1-C10)-alkylthio-(C1-C10)-alkyl, (C6-C10)-aryl-(C1-C10)-alkyl, 5- or 6-membered heteroaryl comprising one nitrogen atom (N) or one oxygen atom (O), 5- or 6-membered heteroaryl comprising one atom N condensed with (C6-C10)-aryl ring, 5- or 6-membered heteroaryl comprising one atom N or one atom O, (C1-C10)-alkyl, cycloheteroalkyl that represents (C5-C8)-saturated ring comprising one heteroatom, such as N or O; if necessary, all compounds comprise 1, 2, 3, 4 or 5 groups of substitutes at corresponding carbon atom chosen from halogen atom, (C1-C10)-alkyl, (C2-C12)-alkenyl, hydroxy-group, hydroxy-(C1-C10)-alkyl or cyano-group; R1 and R4 can form in common, if necessary, the group -(CR5R6)m- wherein m means 2-6, and R5 and R6 are similar or different and chosen independently from hydroxy-group, H or (C1-C10)-alkyl including all their stereoisomers; and their pharmaceutically acceptable salt, or prodrug esters and all their stereoisomers. These compound inhibit activity of dipeptidyl peptidase IV that allows their using in pharmaceutical compositions used in treatment of diabetes mellitus of type-2.
EFFECT: valuable medicinal properties of compounds.
20 cl, 6 tbl, 113 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF ALPHA-(N-SULFONAMIDO)ACETAMIDE AS INHIBITORS OF BETA-AMYLOID | 2002 |
|
RU2300518C2 |
OXA- AND THIAZOLE-DERIVATIVES AS ANTIDIABETIC AGENTS AND AGENTS AGAINST OBESITY | 2000 |
|
RU2279427C2 |
CYCLIC INHIBITORS OF PROTEIN-TYROSINE KINASES | 2000 |
|
RU2260592C9 |
LIGANDS OF THYROID RECEPTORS: DERIVATIVES OF ANILINE | 2001 |
|
RU2260586C2 |
COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS | 2005 |
|
RU2416606C2 |
MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
TRIPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES, PHARMACEUTICAL COMPOSITION SHOWING INHIBITING ACTIVITY WITH RESPECT TO THROMBIN AMIDASE | 1994 |
|
RU2105010C1 |
MODULATORS CCR2 | 2016 |
|
RU2726206C2 |
OXA- AND THIAZOLE DERIVATIVES AS ANTIDIABETIC AGENTS AND ANTI-FAT AGENTS | 2000 |
|
RU2327692C2 |
DERIVATIVES OF PIPERAZINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USING AS CCR5 ANTAGONISTS | 2000 |
|
RU2299206C9 |
Authors
Dates
2006-11-10—Published
2001-03-05—Filed